Compare RMD & MTD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RMD | MTD |
|---|---|---|
| Founded | 1989 | 1991 |
| Country | United States | Switzerland |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.6B | 28.6B |
| IPO Year | 1996 | 1997 |
| Metric | RMD | MTD |
|---|---|---|
| Price | $253.16 | $1,665.51 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 13 |
| Target Price | $251.52 | ★ $1,525.67 |
| AVG Volume (30 Days) | ★ 875.9K | 184.8K |
| Earning Date | 10-29-2026 | 11-05-2026 |
| Dividend Yield | ★ 1.04% | N/A |
| EPS Growth | ★ 9.67 | 3.88 |
| EPS | 10.43 | ★ 19.87 |
| Revenue | $2,957,013,000.00 | ★ $4,026,399,000.00 |
| Revenue This Year | $2.66 | $5.30 |
| Revenue Next Year | $6.46 | $4.74 |
| P/E Ratio | ★ $24.28 | $83.49 |
| Revenue Growth | ★ 13.44 | 3.98 |
| 52 Week Low | $180.27 | $1,023.05 |
| 52 Week High | $277.67 | $1,713.39 |
| Indicator | RMD | MTD |
|---|---|---|
| Relative Strength Index (RSI) | 75.97 | 70.99 |
| Support Level | $247.01 | $1,239.25 |
| Resistance Level | $262.16 | N/A |
| Average True Range (ATR) | 5.45 | 36.78 |
| MACD | 2.28 | 3.76 |
| Stochastic Oscillator | 92.12 | 77.24 |
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks, and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea, combined with aging populations and increasing prevalence of obesity, is resulting in a structurally growing market. The company earns roughly two-thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan, and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor, and payer in the out-of-hospital setting.
Mettler-Toledo supplies weighing and precision instruments to customers in the life sciences (around 55% of sales), industrial (around 40%), and food retail (around 5%) industries. Its products include laboratory and retail scales, pipettes, pH meters, thermal analysis equipment, titrators, metal detectors, and X-ray analyzers. Mettler leads the market for weighing instrumentation and controls more than 50% of the market for lab balances. The business is geographically diversified, with the Americas accounting for about 37% of sales, Europe about 27%, China about 16% and the rest of the world about 20%.